Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome
-
* Corresponding author: Azra Raza araza@aptiumoncology.com
Journal of Hematology & Oncology 2009, 2:20 doi:10.1186/1756-8722-2-20
Accesses
- Last 30 days: 108 accesses
- Last 365 days: 962 accesses
- All time: 3732 accesses